Literature DB >> 12354841

Thermal ablation therapy for hepatocellular carcinoma.

Muneeb Ahmed1, S Nahum Goldberg.   

Abstract

Thermal ablation strategies, including the use of radiofrequency, microwaves, lasers, and high-intensity focused ultrasound, are gaining increasing attention as an alternative to standard surgical therapies in the treatment of primary hepatocellular carcinoma. Benefits over surgical resection include the anticipated reduction in morbidity and mortality, low cost, suitability for real-time imaging guidance, ability to perform ablative procedures on an outpatient basis, and the potential application in a wider spectrum of patients-including those who are not surgical candidates. In this review, the authors examine the reported clinical success of each of these four therapies, potential complications, current limitations, and future directions of development.

Entities:  

Mesh:

Year:  2002        PMID: 12354841     DOI: 10.1016/s1051-0443(07)61791-6

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  19 in total

1.  Strategy for accurate liver intervention by an optical tracking system.

Authors:  Qinyong Lin; Rongqian Yang; Ken Cai; Peifeng Guan; Weihu Xiao; Xiaoming Wu
Journal:  Biomed Opt Express       Date:  2015-08-07       Impact factor: 3.732

2.  Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.

Authors:  Ming-De Lu; Hui-Xiong Xu; Xiao-Yan Xie; Xiao-Yu Yin; Jun-Wei Chen; Ming Kuang; Zuo-Feng Xu; Guang-Jian Liu; Yan-Lin Zheng
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 7.527

3.  Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

Authors:  Ihab R Kamel; Eleni Liapi; Diane K Reyes; Marianna Zahurak; David A Bluemke; Jean-François H Geschwind
Journal:  Radiology       Date:  2009-02       Impact factor: 11.105

4.  Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.

Authors:  Dong-Hyun Kim; Andrew C Larson
Journal:  Interv Oncol 360       Date:  2016-11-17

Review 5.  Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.

Authors:  Muneeb Ahmed; Marwan Moussa; S Nahum Goldberg
Journal:  Chem Phys Lipids       Date:  2011-12-14       Impact factor: 3.329

6.  Evaluation of important treatment parameters in supraphysiological thermal therapy of human liver cancer HepG2 cells.

Authors:  Bhavik Shah; Sankha Bhowmick
Journal:  Ann Biomed Eng       Date:  2006-10-10       Impact factor: 3.934

Review 7.  Management of hepatocellular cancer.

Authors:  Mary F Mulcahy
Journal:  Curr Treat Options Oncol       Date:  2005-09

8.  Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Authors:  Yue Zhang; Sarah B White; Jodi R Nicolai; Zhuoli Zhang; Derek L West; Dong-Hyun Kim; A Lee Goodwin; Frank H Miller; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2014-02-18       Impact factor: 11.105

9.  Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma.

Authors:  Erik E Johnson; Brett H Yamane; Ilia N Buhtoiarov; Hillary D Lum; Alexander L Rakhmilevich; David M Mahvi; Stephen D Gillies; Paul M Sondel
Journal:  Clin Cancer Res       Date:  2009-07-28       Impact factor: 12.531

10.  Sonography guided percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of cooperative training on the pretreatment assessment of the operation's feasibility.

Authors:  Min Ju Kim; Hyo K Lim; Dongil Choi; Won Jae Lee; Hyun Chul Rhim; Seonwoo Kim
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.